Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on February 11, 2008

Circulation. 2008
Published online before print February 11, 2008, doi: 10.1161/CIRCULATIONAHA.107.743963
A more recent version of this article appeared on March 11, 2008
This Article
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: March 11, 2008, Volume 117, Number 10
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/10/1283    most recent
CIRCULATIONAHA.107.743963v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, L. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
Related Collections
Right arrow Secondary prevention
Right arrow Nuclear cardiology and PET
Right arrow Chronic ischemic heart disease
Right arrowRelated Article

Submitted on October 3, 2007
Accepted on January 8, 2008

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden. Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy

Leslee J. Shaw PhD*, Daniel S. Berman MD, David J. Maron MD, G. B. John Mancini MD, Sean W. Hayes MD, Pamela M. Hartigan PhD, William S. Weintraub MD, Robert A. O’Rourke MD, Marcin Dada MD, John A. Spertus MD, MPH, Bernard R. Chaitman MD, John Friedman MD, Piotr Slomka PhD, Gary V. Heller MD, PhD, Guido Germano PhD, Gilbert Gosselin MD, Peter Berger MD, William J. Kostuk MD, Ronald G. Schwartz MD, Merill Knudtson MD, Emir Veledar PhD, Eric R. Bates MD, Benjamin McCallister MD, Koon K. Teo MD, William E. Boden MD, for the COURAGE Investigators

From Emory University School of Medicine, Atlanta, Ga (L.J.S., E.V.); Cedars-Sinai Medical Center, Los Angeles, Calif (D.S.B., S.W.H., J.F., P.S., G. Germano); Vanderbilt University Medical Center, Nashville, Tenn (D.J.M.); Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada (G.B.J.M.); Veterans Affairs Cooperative Studies Program Coordinating Center, Veterans Affairs Connecticut Healthcare System, West Haven (P.M.H.); Christiana Care Health System, Newark, Del (W.S.W.); South Texas Veterans Health Care System, San Antonio, Tex (R.A.O., G.V.H.); Hartford Hospital, Hartford, Conn (M.D.); Mid America Heart Institute/University of Missouri–Kansas City, Kansas City, Mo (J.A.S., B.M.); St Louis University, St Louis, Mo (B.R.C.); Montreal Heart Institute, Montreal, Quebec, Canada (G. Gosselin); Geisinger Clinic, Danville, Pa (P.B.); London Health Sciences Centre, London, Ontario, Canada (W.J.K.); University of Rochester, Rochester, NY (R.G.S.); Foothills Hospital, Calgary, Alberta, Canada (M.K.); University of Michigan, Ann Arbor (E.R.B.); McMaster University, Hamilton, Ontario, Canada (K.K.T.); and Western New York Veterans Affairs Healthcare Network/Buffalo General Hospital/State University of New York, Buffalo (W.E.B.).

* To whom correspondence should be addressed. E-mail: leslee.shaw{at}emory.edu.

Background—Extent and severity of myocardial ischemia are determinants of risk for patients with coronary artery disease, and ischemia reduction is an important therapeutic goal. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) nuclear substudy compared the effectiveness of percutaneous coronary intervention (PCI) for ischemia reduction added to optimal medical therapy (OMT) with the use of myocardial perfusion single photon emission computed tomography (MPS).

Methods and Results—Of the 2287 COURAGE patients, 314 were enrolled in this substudy of serial rest/stress MPS performed before treatment and 6 to 18 months (mean=374±50 days) after randomization using paired exercise (n=84) or vasodilator stress (n=230). A blinded core laboratory analyzed quantitative MPS measures of percent ischemic myocardium. Moderate to severe ischemia encumbered ≥10% myocardium. The primary end point was ≥5% reduction in ischemic myocardium at follow-up. Treatment groups had similar baseline characteristics. At follow-up, the reduction in ischemic myocardium was greater with PCI+OMT (-2.7%; 95% confidence interval, -1.7%, -3.8%) than with OMT (-0.5%; 95% confidence interval, -1.6%, 0.6%; P<0.0001). More PCI+OMT patients exhibited significant ischemia reduction (33% versus 19%; P=0.0004), especially patients with moderate to severe pretreatment ischemia (78% versus 52%; P=0.007). Patients with ischemia reduction had lower unadjusted risk for death or myocardial infarction (P=0.037 [risk-adjusted P=0.26]), particularly if baseline ischemia was moderate to severe (P=0.001 [risk-adjusted P=0.08]). Death or myocardial infarction rates ranged from 0% to 39% for patients with no residual ischemia to ≥10% residual ischemia on follow-up MPS (P=0.002 [risk-adjusted P=0.09]).

Conclusions—In COURAGE patients who underwent serial MPS, adding PCI to OMT resulted in greater reduction in ischemia compared with OMT alone. Our findings suggest a treatment target of ≥5% ischemia reduction with OMT with or without coronary revascularization.


Key words: ischemia • perfusion • prevention • prognosis


Related Article:

Clinical Summaries
Circulation 2008 117: 1247. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
G. Sarno, I. Decraemer, P. K. Vanhoenacker, B. De Bruyne, M. Hamilos, T. Cuisset, E. Wyffels, J. Bartunek, G. R. Heyndrickx, and W. Wijns
On the Inappropriateness of Noninvasive Multidetector Computed Tomography Coronary Angiography to Trigger Coronary Revascularization: A Comparison With Invasive Angiography
J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 550 - 557.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
D. S. Berman and J. K. Min
Can Coronary Computed Tomographic Angiography Trigger Coronary Revascularization?: Questioning the Appropriateness of the Question
J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 558 - 560.
[Full Text] [PDF]


Home page
NEJMHome page
R. P. Giugliano, J. A. White, C. Bode, P. W. Armstrong, G. Montalescot, B. S. Lewis, A. van `t Hof, L. G. Berdan, K. L. Lee, J. T. Strony, et al.
Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
N. Engl. J. Med., May 21, 2009; 360(21): 2176 - 2190.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
E. Nagel, J. A.C. Lima, R. T. George, and C. M. Kramer
Newer methods for noninvasive assessment of myocardial perfusion cardiac magnetic resonance or cardiac computed tomography?
J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 656 - 660.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
J. K. Min and D. Berman
Anatomic and Functional Assessment of Coronary Artery Disease: Convergence of 2 Aims in a Single Setting
Circ Cardiovasc Imaging, May 1, 2009; 2(3): 163 - 165.
[Full Text] [PDF]


Home page
HeartHome page
K. A A Fox
COURAGE to change practice? Revascularisation in patients with stable coronary artery disease
Heart, May 1, 2009; 95(9): 689 - 692.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
E. Nagel
Taking the Last Hurdles: Magnetic Resonance Myocardial Perfusion Imaging
J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 434 - 436.
[Full Text] [PDF]


Home page
Heart AsiaHome page
T Chua
The evolving role of molecular imaging for coronary artery disease: where do we stand today?
Heart Asia, March 6, 2009; 2009(2): 1 - 5.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Husmann, B. A. Herzog, O. Gaemperli, F. Tatsugami, N. Burkhard, I. Valenta, P. Veit-Haibach, C. A. Wyss, U. Landmesser, and P. A. Kaufmann
Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating
Eur. Heart J., March 1, 2009; 30(5): 600 - 607.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. Stirrup, K. Wechalekar, A. Maenhout, and C. Anagnostopoulos
Cardiac radionuclide imaging in stable coronary artery disease and acute coronary syndromes
Br. Med. Bull., March 1, 2009; 89(1): 63 - 78.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. Neglia and A. L'Abbate
Myocardial Perfusion Reserve in Ischemic Heart Disease
J. Nucl. Med., February 1, 2009; 50(2): 175 - 177.
[Full Text] [PDF]


Home page
NEJMHome page
P. A.L. Tonino, B. De Bruyne, N. H.J. Pijls, U. Siebert, F. Ikeno, M. van `t Veer, V. Klauss, G. Manoharan, T. Engstrom, K. G. Oldroyd, et al.
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
N. Engl. J. Med., January 15, 2009; 360(3): 213 - 224.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. G. Ellis
Refining the Art and Science of Coronary Stenting
N. Engl. J. Med., January 15, 2009; 360(3): 292 - 294.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The year in cardiac imaging.
J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70.
[Full Text] [PDF]


Home page
CirculationHome page
S. B. Joshi
Letter by Joshi Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy"
Circulation, December 16, 2008; 118(25): e838 - e838.
[Full Text] [PDF]


Home page
CirculationHome page
G. Tarantini, R. Razzolini, and S. Iliceto
Letter by Tarantini et al Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy"
Circulation, December 16, 2008; 118(25): e839 - e839.
[Full Text] [PDF]


Home page
CirculationHome page
L. J. Shaw, E. Veledar, D. S. Berman, S. W. Hayes, J. Friedman, P. Slomka, G. Germano, D. J. Maron, G. B. J. Mancini, P. M. Hartigan, et al.
Response to Letters Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy"
Circulation, December 16, 2008; 118(25): e840 - e841.
[Full Text] [PDF]


Home page
JAMAHome page
G. A. Lin, R. A. Dudley, F. L. Lucas, D. J. Malenka, E. Vittinghoff, and R. F. Redberg
Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention
JAMA, October 15, 2008; 300(15): 1765 - 1773.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. A. Diamond and S. Kaul
The Disconnect Between Practice Guidelines and Clinical Practice--Stressed Out
JAMA, October 15, 2008; 300(15): 1817 - 1819.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Percutaneous Coronary Intervention Reduces Ischemia in COURAGE Substudy
Journal Watch Cardiology, April 30, 2008; 2008(430): 3 - 3.
[Full Text]